Fundz

Circular Genomics reported raising $8.3 Million in an initial SEC Form D filing, from an offering of $15 Million

PRIVATEJan 23, 2024$8.3M of $15M raised

Amount Raised

$8.3 Million

$8.3 Million sold, per SEC Form D (first sale Jan 11, 2024)

Round Type

Venture

AlbuquerqueBiotechnology

Who else raised in Biotechnology around the same time

Companies in the same sectors as Circular Genomics that raised within 45 days of this round, from Fundz verified event records.

  • Frontier Medicines Corp raised $80M (Series C) on February 25, 2024.
  • DeepLook Medical raised $1.7M (Seed) on February 23, 2024.
  • Lumicell raised $2.3M (Seed) on February 22, 2024.
  • Frontier Medicines Corp raised $80M (Series C) on February 22, 2024.
  • Simple Planet raised $6M (Series A) on February 22, 2024.
  • Samphire Neuroscience raised $2.3M (Pre-Seed) on February 21, 2024.

Who to call at Circular Genomics, and when

A new round usually means Circular Genomics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Circular Genomics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Circular Genomics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Circular Genomics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Circular Genomics

Location

5901 INDIAN SCHOOL RD NE

Albuquerque, New Mexico, United States

About

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Circular Genomics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contacts9 people are listed at Circular Genomics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Circular Genomics's next move

See what Strategic adds

Circular Genomics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.